The company is focused on the commercialization of its proprietary Matrix-M adjuvant and is rapidly advancing its COVID-19-Influenza Combination (CIC) vaccine to Phase 3. Here are some key details ...

Patients with resectable stage 3 melanoma should talk about pretreatment therapy with their cancer care teams, an expert said ...

A study finds 1 year of avelumab treatment improves distant disease free and overall survival rates in patients with early ...

A small retrospective study found that combining obinutuzumab with radiation therapy may offer a viable and well-tolerated ...

Review demonstrates curcumin's neuroprotective effects in neurodegenerative diseases, enhancing its potential through ...

Armaghani, MD, highlights two key presentations. First, a retrospective study on adjuvant endocrine therapy in ER-low breast ...

Lynn Schuchter, MD, director of the Tara Miller Melanoma Center and Madlyn and Leonard Abramson Professor of Clinical ...

Novavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the best-performing companies in New York.

Two courses of neoadjuvant ipilimumab/nivolumab highly improve event free survival (EFS) in patients with macroscopic stage 3 ...

Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by ...

There was no significant difference in metastasis-free survival between the ADT and non-ADT groups over 10 years. 2. Adverse ...